Important Announcements

ACL Laboratories continuously strives to provide the best laboratory services possible. Our Test Bulletins and Important Announcements include information regarding new test offerings, changes in test procedures, reference range changes, or modifications in specimen collection protocol and/or new specimen collection devices.

mar. 25, 2019

April 2019 Test Bulletin

Urine Erythrocyte (ERYT) Reference Range and Reporting Range Changes for Asymptomatic MicroHematuria (AMH) -- ACL Laboratories Discontinues In-house Testing for Test Order Codes: CY2C19, CYP2D6, HBVGT, TISSMSI -- ALT (Test Order Code GPT) Reference Range Update Read more

feb. 28, 2019

March 2019 Test Bulletin

ACL Laboratories Updates Cytogenetics Testing Forms -- ACL Laboratories Offers New Reportable HIV Integrase Drug for Test Order Code HIVING -- Inactivated Code with REF Code Read more

jan. 30, 2019

February 2019 Test Bulletin

ACL Laboratories Offers Comprehensive Drug Screen – Pain Management Profile 1 (Test Order Code QPNMG1) and deactivates Drug Abuse Panel – Drug Management (Test Order Code DMABUS) -- Pain Management Drug Panel (Test Order Code DRGPM2) -- Pain Management Drug Screen with Interpretation (Test Order Code DRUGPM) Read more

jan. 10, 2019

January 2019 Test Bulletin

ACL Laboratories Implements New Genetic Test Panel for Prenatal Carrier Screening -- Reference Laboratory Discontinues Test Order Codes JAK2R and REF801 -- Notification of Change: Cigna Coverage Policy for Molecular Microbe Testing -- ACL Laboratories Discontinues Treponema Pallidum Antibody, IgG by IFA (FTA-ABS), Serum (Test Order Code FTABR) Read more

dec. 03, 2018

December 2018 Test Bulletin

ACL Implements New Methodology for HSV 1 and 2 Qualitative Testing -- Blue Cross Blue Shield Medicaid Currently Following CMS NCD Guidelines for Medicaid Plan -- Swabone™ MYC/Ureaplasma Panel by PCR (Test Order Code SWOMU) replaces Ureaplasma & Mycoplasma Culture (Test Order Code MYURER) -- 2019 CPT Code Changes -- ACL Specimen Processing Changes Read more